Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models

Valentina Del Dotto, Mario Fogazza, Francesco Musiani, Alessandra Maresca, Serena J. Aleo, Leonardo Caporali, Chiara La Morgia, Cecilia Nolli, Tiziana Lodi, Paola Goffrini, David Chan, Valerio Carelli, Michela Rugolo, Enrico Baruffini, Claudia Zanna

Research output: Contribution to journalArticle

Abstract

OPA1 is the major gene responsible for Dominant Optic Atrophy (DOA) and the syndromic form DOA “plus”. Over 370 OPA1 mutations have been identified so far, although their pathogenicity is not always clear. We have analyzed one novel and a set of known OPA1 mutations to investigate their impact on protein functions in primary skin fibroblasts and in two “ad hoc” generated cell systems: the MGM1/OPA1 chimera yeast model and the Opa1−/− MEFs model expressing the mutated human OPA1 isoform 1. The yeast model allowed us to confirm the deleterious effects of these mutations and to gain information on their dominance/recessivity. The MEFs model enhanced the phenotypic alteration caused by mutations, nicely correlating with the clinical severity observed in patients, and suggested that the DOA “plus” phenotype could be induced by the combinatorial effect of mitochondrial network fragmentation with variable degrees of mtDNA depletion. Overall, the two models proved to be valuable tools to functionally assess and define the deleterious mechanism and the pathogenicity of novel OPA1 mutations, and useful to testing new therapeutic interventions.

Original languageEnglish
Pages (from-to)3496-3514
Number of pages19
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1864
Issue number10
DOIs
Publication statusPublished - Oct 1 2018

Fingerprint

Autosomal Dominant Optic Atrophy
Virulence
Yeasts
Mutation
Mitochondrial DNA
Protein Isoforms
Fibroblasts
Phenotype
Skin
Genes
Proteins
Therapeutics

Keywords

  • Dominant Optic Atrophy (DOA)
  • Mitochondrial functions
  • Mitochondrial network
  • mtDNA
  • OPA1
  • OPA1 mutations

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology

Cite this

Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models. / Del Dotto, Valentina; Fogazza, Mario; Musiani, Francesco; Maresca, Alessandra; Aleo, Serena J.; Caporali, Leonardo; La Morgia, Chiara; Nolli, Cecilia; Lodi, Tiziana; Goffrini, Paola; Chan, David; Carelli, Valerio; Rugolo, Michela; Baruffini, Enrico; Zanna, Claudia.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, No. 10, 01.10.2018, p. 3496-3514.

Research output: Contribution to journalArticle

Del Dotto, V, Fogazza, M, Musiani, F, Maresca, A, Aleo, SJ, Caporali, L, La Morgia, C, Nolli, C, Lodi, T, Goffrini, P, Chan, D, Carelli, V, Rugolo, M, Baruffini, E & Zanna, C 2018, 'Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models', Biochimica et Biophysica Acta - Molecular Basis of Disease, vol. 1864, no. 10, pp. 3496-3514. https://doi.org/10.1016/j.bbadis.2018.08.004
Del Dotto, Valentina ; Fogazza, Mario ; Musiani, Francesco ; Maresca, Alessandra ; Aleo, Serena J. ; Caporali, Leonardo ; La Morgia, Chiara ; Nolli, Cecilia ; Lodi, Tiziana ; Goffrini, Paola ; Chan, David ; Carelli, Valerio ; Rugolo, Michela ; Baruffini, Enrico ; Zanna, Claudia. / Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models. In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 2018 ; Vol. 1864, No. 10. pp. 3496-3514.
@article{4b9a5e6554b04f51aae0c35aecf976da,
title = "Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models",
abstract = "OPA1 is the major gene responsible for Dominant Optic Atrophy (DOA) and the syndromic form DOA “plus”. Over 370 OPA1 mutations have been identified so far, although their pathogenicity is not always clear. We have analyzed one novel and a set of known OPA1 mutations to investigate their impact on protein functions in primary skin fibroblasts and in two “ad hoc” generated cell systems: the MGM1/OPA1 chimera yeast model and the Opa1−/− MEFs model expressing the mutated human OPA1 isoform 1. The yeast model allowed us to confirm the deleterious effects of these mutations and to gain information on their dominance/recessivity. The MEFs model enhanced the phenotypic alteration caused by mutations, nicely correlating with the clinical severity observed in patients, and suggested that the DOA “plus” phenotype could be induced by the combinatorial effect of mitochondrial network fragmentation with variable degrees of mtDNA depletion. Overall, the two models proved to be valuable tools to functionally assess and define the deleterious mechanism and the pathogenicity of novel OPA1 mutations, and useful to testing new therapeutic interventions.",
keywords = "Dominant Optic Atrophy (DOA), Mitochondrial functions, Mitochondrial network, mtDNA, OPA1, OPA1 mutations",
author = "{Del Dotto}, Valentina and Mario Fogazza and Francesco Musiani and Alessandra Maresca and Aleo, {Serena J.} and Leonardo Caporali and {La Morgia}, Chiara and Cecilia Nolli and Tiziana Lodi and Paola Goffrini and David Chan and Valerio Carelli and Michela Rugolo and Enrico Baruffini and Claudia Zanna",
note = "Ricercatori distaccati presso IRCCS a seguito Convenzione esclusiva con Universit{\`a} di Bologna (La Morgia Chiara, Carelli Valerio)",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.bbadis.2018.08.004",
language = "English",
volume = "1864",
pages = "3496--3514",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "10",

}

TY - JOUR

T1 - Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models

AU - Del Dotto, Valentina

AU - Fogazza, Mario

AU - Musiani, Francesco

AU - Maresca, Alessandra

AU - Aleo, Serena J.

AU - Caporali, Leonardo

AU - La Morgia, Chiara

AU - Nolli, Cecilia

AU - Lodi, Tiziana

AU - Goffrini, Paola

AU - Chan, David

AU - Carelli, Valerio

AU - Rugolo, Michela

AU - Baruffini, Enrico

AU - Zanna, Claudia

N1 - Ricercatori distaccati presso IRCCS a seguito Convenzione esclusiva con Università di Bologna (La Morgia Chiara, Carelli Valerio)

PY - 2018/10/1

Y1 - 2018/10/1

N2 - OPA1 is the major gene responsible for Dominant Optic Atrophy (DOA) and the syndromic form DOA “plus”. Over 370 OPA1 mutations have been identified so far, although their pathogenicity is not always clear. We have analyzed one novel and a set of known OPA1 mutations to investigate their impact on protein functions in primary skin fibroblasts and in two “ad hoc” generated cell systems: the MGM1/OPA1 chimera yeast model and the Opa1−/− MEFs model expressing the mutated human OPA1 isoform 1. The yeast model allowed us to confirm the deleterious effects of these mutations and to gain information on their dominance/recessivity. The MEFs model enhanced the phenotypic alteration caused by mutations, nicely correlating with the clinical severity observed in patients, and suggested that the DOA “plus” phenotype could be induced by the combinatorial effect of mitochondrial network fragmentation with variable degrees of mtDNA depletion. Overall, the two models proved to be valuable tools to functionally assess and define the deleterious mechanism and the pathogenicity of novel OPA1 mutations, and useful to testing new therapeutic interventions.

AB - OPA1 is the major gene responsible for Dominant Optic Atrophy (DOA) and the syndromic form DOA “plus”. Over 370 OPA1 mutations have been identified so far, although their pathogenicity is not always clear. We have analyzed one novel and a set of known OPA1 mutations to investigate their impact on protein functions in primary skin fibroblasts and in two “ad hoc” generated cell systems: the MGM1/OPA1 chimera yeast model and the Opa1−/− MEFs model expressing the mutated human OPA1 isoform 1. The yeast model allowed us to confirm the deleterious effects of these mutations and to gain information on their dominance/recessivity. The MEFs model enhanced the phenotypic alteration caused by mutations, nicely correlating with the clinical severity observed in patients, and suggested that the DOA “plus” phenotype could be induced by the combinatorial effect of mitochondrial network fragmentation with variable degrees of mtDNA depletion. Overall, the two models proved to be valuable tools to functionally assess and define the deleterious mechanism and the pathogenicity of novel OPA1 mutations, and useful to testing new therapeutic interventions.

KW - Dominant Optic Atrophy (DOA)

KW - Mitochondrial functions

KW - Mitochondrial network

KW - mtDNA

KW - OPA1

KW - OPA1 mutations

UR - http://www.scopus.com/inward/record.url?scp=85051272945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051272945&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2018.08.004

DO - 10.1016/j.bbadis.2018.08.004

M3 - Article

C2 - 30293569

AN - SCOPUS:85051272945

VL - 1864

SP - 3496

EP - 3514

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 10

ER -